Androgen deprivation-induced elevated nuclear SIRT1 promotes prostate tumor cell survival by reactivation of AR signaling

Shih Bo Huang, D. Thapa, A. R. Munoz, S. S. Hussain, X. Yang, R. G. Bedolla, P. Osmulski, M. E. Gaczynska, Z. Lai, Yu Chiao Chiu, Li Ju Wang, Y. Chen, P. Rivas, C. Shudde, R. L. Reddick, H. Miyamoto, R. Ghosh, A. P. Kumar

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


The NAD+-dependent deacetylase, Sirtuin 1 (SIRT1) is involved in prostate cancer pathogenesis. However, the actual contribution is unclear as some reports propose a protective role while others suggest it is harmful. We provide evidence for a contextual role for SIRT1 in prostate cancer. Our data show that (i) mice orthotopically implanted with SIRT1-silenced LNCaP cells produced smaller tumors; (ii) SIRT1 suppression mimicked AR inhibitory effects in hormone responsive LNCaP cells; and (iii) caused significant reduction in gene signatures associated with E2F and MYC targets in AR-null PC-3 and E2F and mTORC1 signaling in castrate-resistant ARv7 positive 22Rv1 cells. Our findings further show increased nuclear SIRT1 (nSIRT1) protein under androgen-depleted relative to androgen-replete conditions in prostate cancer cell lines. Silencing SIRT1 resulted in decreased recruitment of AR to PSA enhancer selectively under androgen-deprivation conditions. Prostate cancer outcome data show that patients with higher levels of nSIRT1 progress to advanced disease relative to patients with low nSIRT1 levels. Collectively, we demonstrate that lowering SIRT1 levels potentially provides new avenues to effectively prevent prostate cancer recurrence.

Original languageEnglish (US)
Pages (from-to)24-36
Number of pages13
JournalCancer Letters
StatePublished - May 1 2021
Externally publishedYes


  • AR
  • Biochemical recurrence
  • Prostate cancer
  • SIRT1

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Androgen deprivation-induced elevated nuclear SIRT1 promotes prostate tumor cell survival by reactivation of AR signaling'. Together they form a unique fingerprint.

Cite this